Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Quadriplegic doctor obtains degree against all odds
2016-11-25

Description: Dr Swartbooi CUADS Tags: Dr Swartbooi CUADS

Dr Swartbooi faces each day with vigour and
resilience. Dr Swartbooi analyses images on
a screen in the Clinical Imaging Laboratory
at Universitas Academic Hospital.

Photo: Oteng Mpete

Life’s defining moments are when perseverance is rewarded. It is not easy to swim against the tide. However, for Dr Ambrotius Swartbooi from the University of the Free State’s Department of Clinical Imaging Sciences, it became his moment of glory. In 2006, Dr Swartbooi suffered a spinal injury from a near-fatal car accident which left him paralysed and a quadriplegic.

The strength to carry on

“You have one of two choices:
to lie down and give up,
or to pick yourself up”
—Dr Swartbooi

Dr Swartbooi spent close to six months, recovering from his injuries. “You have one of two choices: to lie down and give up or to pick yourself up,” said Dr Swartbooi. He would inspire other patients with similar injuries to reintegrate into society despite their new-found circumstances.

Fortunately, not all was doom and gloom; in 2007 Dr Swartbooi got married, and his wife has supported and inspired him to continue pursuing his dreams. Dr Swartbooi completed his undergraduate medical degree at the UFS, and in 2014 decided it was time to complete his studies and pursued an MMed specialising in Diagnostic Radiology.

To treat or not treat: that is the question

After all his trials and tribulations, Dr Swartbooi will be receiving his MMed Diagnostic Radiology degree at the UFS Summer Graduation ceremony in December 2016. His research focuses on intracranial aneurysm size interventions. He discovered that there were discrepancies between international standards for intervention and African standards for intervention.

The research inspects what should be treated and how it should be treated. He found there was a gap in African literature into the size of aneurysms.

Champion of survival: Where to from here?

“That’s a good question,” said Dr Swartbooi. “Slowly from here. I still need to work on getting my full accreditation from the Health Professions Council of South Africa (HPCSA).” He plans to continue fuelling his passion for teaching. “There is no place better to teach than at an academic hospital.”

Dr Swartbooi commended the efforts of the Centre for Universal Access and Disability Support (CUADS), which assisted him in writing all his exams. “I want to be able to make a fulfilling and lasting impact on people but also to give the best medical service that I can,” concluded Dr Swartbooi.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept